Content Block Tag: NRG-CC001
‘NRG-CC001 Documentation’ of page ‘NRG-CC001’
Protocol Documents NRG-CC001 Protocol NRG-CC001 Consent NRG-CC001 Track Amendments/Update NRG-CC001 Summary of Changes Memos and Letters IND Exemption Letter Initial Study Activation Memo NRG-CC001 Neurocognitive Testing IRB Memo NRG-CC001-Instructions NRG-CC001 Neurocognitive Training Procedure Letter NRG-CC001 Study Memorandum 09-10-15 NRG-CC001 Study Memorandum 10-3-16 Frequently Asked Questions Document FAQ 10-27-2015 FAQ Imaging 4-18-16 Forms NRG-CC001 Certification Worksheet […]
Read More
‘NRG-CC001: A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases’ of page ‘NRG-CC001’
Principal Investigator/Co-Principal Investigator Paul Brown, MD/ Vinai Gondi, MD Primary Objective To determine whether the addition of HA-WBRT increases time to neurocognitive failure at months 2, 4, 6 and 12 as measured by neurocognitive decline on a battery of tests: the Hopkins Verbal Learning Test-Revised (HVLT-R) for Total Recall, Delayed Recall, and Delayed Recognition, Controlled […]
Read More